Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 202
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 50MG/12,5MG/200MG TBL FLM 100
0234560 27/ 006/16-C levodopaca.pdf levodopaca.pdf N04BA03 R
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 50MG/12,5MG/200MG TBL FLM 30
0234561 27/ 006/16-C levodopaca.pdf levodopaca.pdf N04BA03 R
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 50MG/12,5MG/200MG TBL FLM 100
0234562 27/ 006/16-C levodopaca.pdf levodopaca.pdf N04BA03 R
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 50MG/12,5MG/200MG TBL FLM 30
0234563 27/ 006/16-C levodopaca.pdf levodopaca.pdf N04BA03 R
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 150 MG/37,5 MG/200 MG 150MG/37,5MG/200MG TBL FLM 100
0214878 27/ 008/16-C     N04BA03 B
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 200 MG/50 MG/200 MG 200MG/50MG/200MG TBL FLM 30
0214879 27/ 009/16-C     N04BA03 B
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 200 MG/50 MG/200 MG 200MG/50MG/200MG TBL FLM 100
0214880 27/ 009/16-C     N04BA03 B
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 200 MG/50 MG/200 MG 200MG/50MG/200MG TBL FLM 30
0214881 27/ 009/16-C     N04BA03 B
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 200 MG/50 MG/200 MG 200MG/50MG/200MG TBL FLM 100
0214882 27/ 009/16-C     N04BA03 B
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 50 MG/12,5 MG/200 MG 50MG/12,5MG/200MG TBL FLM 100
0214867 27/ 006/16-C     N04BA03 B
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 50 MG/12,5 MG/200 MG 50MG/12,5MG/200MG TBL FLM 30
0214868 27/ 006/16-C     N04BA03 B
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 50 MG/12,5 MG/200 MG 50MG/12,5MG/200MG TBL FLM 100
0214869 27/ 006/16-C     N04BA03 B
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 50 MG/12,5 MG/200 MG 50MG/12,5MG/200MG TBL FLM 30
0214870 27/ 006/16-C     N04BA03 B
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 100 MG/25 MG/200 MG 100MG/25MG/200MG TBL FLM 30
0214871 27/ 007/16-C     N04BA03 B
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 100 MG/25 MG/200 MG 100MG/25MG/200MG TBL FLM 100
0214872 27/ 007/16-C     N04BA03 B
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 100 MG/25 MG/200 MG 100MG/25MG/200MG TBL FLM 30
0214873 27/ 007/16-C     N04BA03 B
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 100 MG/25 MG/200 MG 100MG/25MG/200MG TBL FLM 100
0214874 27/ 007/16-C     N04BA03 B
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 150 MG/37,5 MG/200 MG 150MG/37,5MG/200MG TBL FLM 30
0214875 27/ 008/16-C     N04BA03 B
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 150 MG/37,5 MG/200 MG 150MG/37,5MG/200MG TBL FLM 100
0214876 27/ 008/16-C     N04BA03 B
LEVODOPA/CARBIDOPA/ENTACAPONE MYLAN 150 MG/37,5 MG/200 MG 150MG/37,5MG/200MG TBL FLM 30
0214877 27/ 008/16-C     N04BA03 B

‹‹ ‹ 1 2 3 4 5 6 7 8 10 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 20. April 2021 at 01:09
Last update of price and payment data: 8. April 2021 at 01:09